Browsing by Author "Yıldız, Özcan"
Now showing items 1-20 of 29
-
Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade
Ölmez, Ömer Fatih; Kınıkoğlu, Oğuzcan; Helvacı Yılmaz, Nesrin; Bilici, Ahmet Erkan; Çubukçu, Erdem; Şeker, Mesut Metin; Çakır, Tansel; Yıldız, Özcan; Hamdard, Jamshid (SAGE Publications Ltd, 2019)Paraneoplastic neurological syndrome is associated with anti-Ri antibodies, which are typically present with opsoclonus–myoclonus–ataxia. Human epidermal growth factor receptor 2 (HER2) overexpression is present in 15%–25% ... -
Are pretreatment inflammation-based prognostic scores useful in predicting the outcomes of patients with ALK-positive NSCLC?
Ölmez, Ömer Fatih; Bilici, Ahmet; Gürsoy, Pınar; Çubukçu, Erdem; Yıldız, Özcan; Sakın, Abdullah; Korkmaz, Taner; Çil, İbrahim; Çakar, Beyhan; Menekşe, Serkan; Demir, Tarık; Açıkgöz, Özgen; Hamdard, Jamshid (Elsevier Science, 2019)Background: Approximately 5% of all diagnosed non-small cell lung cancer (NSCLC) patients harbor a genetic rearrangement between the ALK and EML4 genes, representing a specific molecular and clinical subgroup (ALK+ NSCLC). ... -
The comparison of local tumor control after microwave ablation, surgical resection and combined treatment for colorectal liver metastases
Güngören, Fatma Zeynep; Erol, Cengiz; Bilici, Ahmet; Dayangaç, Murat; Şeker, Mehmet; Ölmez, Ömer Fatih; Yaprak, Onur; Yıldız, Özcan; Öncel, Mustafa (ValpoScholar-Valparaiso University, 2022)Aim. We aimed to compare the local therapeutic efficiency of microwave ablation (MWA), surgical resection, and combined treatment, assess the outcomes, and identify predictive factors for local treatment response in ... -
Cost-effectiveness of sorafenib for treatment of radioactive iodine (rai)-refractory locally advanced/metastatic differentiated thyroid cancer (dtc) in Turkey
Erdal, E.; Sayman, Haluk; Türkmen, Cüneyt; Aral, Ferihan; Yıldız, Özcan; Okutur, Kerm; Paralı, E.; Değer, C.; Tunalıoğlu, A.; Sar, Christina; Asan, Simona; Sümer, Fulya Erendağ; Özel, Özgür (Elsevier Science, 2015)OBJECTIVES: Sorafenib is the first product approved for treatment of RAI refractory locally advanced/metastatic DTC patients. This study was conducted in order to analyze cost-effectiveness of sorafenib for treatment of ... -
The effect of music therapy done with traditional turkish music upon the psychological and physical status of cancer patients receiving chemotherapy
Özbek, Hanefi; Doğan, Sibel; Yıldız, Özcan; Bilici, Ahmet; Ölmez, Fatih; Hanoğlu, Lütfü; Ekmen, Güldeniz; Özcan, Nuri; Yaman, Bircan; Yaman, İnci (Wiley-Blackwell, 2015)Background: Cancer incidence and mortality rates are increasing globally. Recently, the use of complementary therapies in Oncology, such as music-based interventions, has increased remarkably. Objective: To assess the ... -
Impact of adjuvant gemcitabine containing chemotherapy following radical nephroureterectomy for patients with upper tract urothelial carcinoma: Results from a propensity-score matched cohort study
Hongda, Zhao; Kang, Liu; Ng, Chi-Fai; de la Rosette, Jean J. M. C. H.; del Pilar Laguna Pes, Maria; Gontero, Paolo; Baard, Joyce; Yıldız, Özcan; Teoh, Jeremy Yuen-Chun (IOS Press BV, 2023)BACKGROUND: The evidence regarding perioperative adjuvant chemotherapy and personalized surveillance strategies for upper tract urothelial carcinoma is limited. OBJECTIVE: To evaluate whether adjuvant gemcitabine ... -
Late relapse of testicular cancer: Recurrence after 24 years and treatment with chemotherapy alone
Akar, Emre; Tural, Deniz; Arslan, Deniz; Başsorgun, Cumhur İbrahim; Yıldız, Özcan (Medknow Publications, 2015)Late relapse of testicular cancer, defined as >2 years interval between initial treatment and recurrence, is a rare disease with the incidence rate of 2.6%. Due to its chemoresistant features, treatment options of late ... -
Meme kanserli hastalarda kemoterapi sonrası bilişsel fonksiyonların aktivite performansı ve aktivite katılım üzerine olan etkisi
Akdemir, Gülhizar; Ünsal, Esra; Tarakçı, Devrim; Bilici, Ahmet; Ölmez, Fatih Ömer; Yıldız, Özcan (AVES, 2021)Amaç: Bilişsel fonksiyon problemleri kemoterapinin en yaygın yan etkileri arasında yer almaktadır. Bireyler tedavi bittikten sonra da bilişsel fonksiyon bozuklukları yaşamaya devam etmektedir. Meme kanseri atlatan bireyler ... -
Modified docetaxel and cisplatin in combination with capecitabine (DCX) as a first-line treatment in HER2- negative advanced gastric cancer
Bilici, Ahmet; Selçukbiricik, Fatih; Demir, Nazan; Öven Ustaalioğlu, Bala Başak; Dikilitaş, Mustafa; Yıldız, Özcan (Asian Pacific Organization for Cancer Prevention, 2014)Background: Docetaxel and cisplatin in combination with fluorouracil (DCF) regimen is accepted to be one of the standard regimens in the treatment of advanced gastric cancer. However, substantial toxicity has limited its ... -
Modified docetaxel and cisplatin in combination with capecitabine (DCX) as first-tine treatment in HER2-negative advanced gastric cancer
Bilici, Ahmet; Selçukbiricik, Fatih; Demir, Nazan; Öven Ustaalioğlu, Bala Başak; Dikillitaş, Mustafa; Yıldız, Özcan (American Society of Clinical Oncology, 2014)… -
The necessity of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma using antiangiogenic targeted therapy after interferon alfa-2b
Mutlu, Hasan; Gündüz, Şeyda; Büyükçelik, Abdullah; Yıldız, Özcan; Uysal, Mükremin; Tural, Deniz; Bozcuk, Hakan; Çoşkun, Hasan Şenol (CIG Media Group, 2014)The effects of cytoreductive nephrectomy (CRN) on prognosis of patients with metastatic renal cell cancer (RCC) using antiangiogenic targeted agents were evaluated. The median overall survival was significantly higher in ... -
PET-CT changes the management and improves outcome in patients with recurrent colorectal cancer
Tural, Deniz; Selçukbiricik, Fatih; Sağer, Sait; Akar, Emre; Yıldız, Özcan; Serdengeçti, Süheyla (Medknow Publications, 2014)Background: The present study aims to analyze the impact of positron emission tomography/computed tomography (PET/CT) on management change in patients with suspected or proven colorectal cancer recurrence, and to assess ... -
Platelet to lymphocyte ratio as a new prognostic for patients with metastatic renal cell cancer
Gündüz, Şeyda Gülenay; Mutlu, Hasan; Tural, Deniz; Yıldız, Özcan; Uysal, Mükremin; Çoşkun, Hasan Şenol; Bozcuk, Hakan Şat (Wiley-Blackwell, 2015)Aim: The objective of this study was to evaluate the blood platelet-lymphocyte ratio (PLR) for its prognostic value in patients with metastatic renal cell cancer (RCC). Methods: We retrospectively reviewed 100 patients ... -
Platelet to lymphocyte ratio is associated with tumor localization and outcomes in metastatic colorectal cancer
Açıkgöz, Özgür; Çakan, Burçin; Demir, Tarık; Bilici, Ahmet; Öven, Bala Başak; Hamdard, Jamshid; Olmuşçelik, Oktay; Ölmez, Ömer Fatih; Şeker, Mesut; Yıldız, Özcan (Lippincott Williams & Wilkins, 2021)The aim of this study was to investigate the predictive and prognostic value of PLR, and the relationship between PLR and tumor localization. A total of 229 patients with de-novo metastatic CRC were retrospectively analyzed. ... -
Platelet to lymphocyte ratio is associated with tumour localization and outcomes in patients with metastatic colorectal cancer
Bilici, Ahmet; Çakan, Banu; Demir, Tarık; Öven, Bala Başak; Açıkgöz, Özgür; Hamdard, Jamshid; Ölmez, Ömer Fatih; Ölmüşçelik, Olcay; Şeker, Mesut; Yıldız, Özcan (Oxford University Press, 2019)Background The prognostic importance of platelet-to-lymphocyte ratio(PLR)has been also investigated in some cancer types including colorectal cancer (CRC).Several studies have found that PLR is associated with poor prognosis ... -
Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer
Tural, Deniz; Selçukbiricik, Fatih; Yıldız, Özcan; Elçin, Olgun; Erdamar, Sibel; Güney, Sabri; Demireli, Fuat; Büyükünal, Evin; Serdengeçti, Süheyla (Springer, 2014)The study populations of previous preoperative chemoradiotherapy (pre-CRT) studies have consisted of mixed clinical stages, such as cT3-cT4 and/or cN positive. For this reason, it has not been possible to demonstrate whether ... -
Prognostic significance of metastatic lymph node ratio in patients with pN3 gastric cancer who underwent curative gastrectom
Bilici, Ahmet; Biricik, Fatih Selçuk; Şeker, Mesut; Öven, Başak Bala; Ölmez, Ömer Fatih; Yıldız, Özcan; Ölmüşçelik, Oktay; Hamdard, Jamshid; Açıkgöz, Özgür; Çakır, Aslı; Kapran, Yersu; Balık, Emre; Öncel, Mustafa (Karger, 2019)Background: Lymph node involvement is an important prognostic factor in patients with gastric cancer. The aim of this study was to determine the prognostic significance of metastatic lymph node ratio (MLNR) and compare it ... -
Prognostic significance of positive lymph node ratio in patients with pN3 gastric cancer who underwent curative gastrectomy
Bilici, Ahmet; Şeker, Mesut; Öven Ustaalıoğlu Bala, Başak; Ölmez, Ömer Fatih; Yıldız, Özcan; Çakır, Aslı; Çağlar, Hale Başak; Öncel, Mustafa (Oxford University Press, 2017)Introduction: Lymph node metastasis is an important prognostic factor for patients with gastric cancer. The aim of this study was to determine the prognostic significance of metastatic lymph node ratio (MLNR) in pN3 gastric ...
